| Having trouble viewing this email? View it as a Web page. 
|  "PNU is a prevention and treatment news summary service. NPIN redistributes summaries as a public service. Inclusion of an article does not constitute CDC endorsement of the content. More details in footer." NOTICE Due to a reduction in funding and competing government priorities the daily CDC HIV/AIDS, Viral Hepatitis, STD and TB Prevention News Update (PNU) service is being discontinued as of June 30, 2014. Between now and June 30, the PNU frequency will change to three times per week. While the government understands the convenience of this service for our stakeholders we hope that you will be able to utilize one of the available news alerts from search engines such as Google and Yahoo to receive disease specific news.
|  6/20/2014 | National News
Rates of Chlamydia, Gonorrhea on the Rise in Alaska
International News
UB-Led Health Care Team to Help Jamaica Fight HIV and HCV
Medical News
Cervical Cancer Vaccinations Are Globally Effective and Economical
Local and Community News
Hepatitis C Testing Continues as NKY Rate Soars
News Briefs
'Take the Test, Take Control' Event Scheduled for June 27
Trying to Produce Drugs Appropriate for Children with HIV
| National News  | Rates of Chlamydia, Gonorrhea on the Rise in Alaska ALASKA :: STDs
Anchorage Daily News (06.18.2014) :: By Tegan Hanlon | | | Anchorage Daily News reported that data recently released by the Alaska Department of Health and Social Services confirmed increases in the state's chlamydia and gonorrhea rates in 2013. The department reported 5,792 new chlamydia cases and 1,135 new gonorrhea cases last year. These rates indicated a significant increase from the previous year, including an approximately 80-percent increase in gonorrhea infections. Youth, women, and minorities had the highest rates, and the northern and southwestern areas of Alaska had the highest prevalence.
The department also published data last month on the state's high syphilis rate in 2013. The data emphasized the connection between this increase and an increase in HIV infections. Anchorage men accounted for most of the increase in syphilis rates, with the majority identifying as bisexual, gay, or having had sex with other men. Many had met their sexual partners online.
Susan Jones, HIV and STD program manager for the state health department, explained that she did not have details on the chlamydia and gonorrhea infections, as the number of cases did not allow for time to interview patients. Alaska has had problems with gonorrhea and chlamydia for some time. CDC has ranked the state's chlamydia rate as highest or second-highest in the country since 2000. Gonorrhea rates had decreased by mid-2012, but have increased once more. According to Jones, preliminary rankings place Alaska first in the nation for chlamydia rates in 2013 and fifth for gonorrhea. |  Read Full Article | Share this Article     | | Back to Top  |  | | International News  | UB-Led Health Care Team to Help Jamaica Fight HIV and HCV JAMAICA :: HIV/AIDS,Viral Hepatitis
University at Buffalo (06.19.2014) :: By Sara Saldi | | | The University at Buffalo (UB) News Center reported that UB faculty and Buffalo business leaders are heading a team that will lend its expertise to assist the Jamaican government in its fight against HIV and hepatitis C virus (HCV). The first project will be to use current initiatives in UB's Center of Excellence in Bioinformatics and Life Sciences' (CBLS) Patient Safety Organization to transition paper medical records in a regional hospital to a national electronic medical record system.
The Jamaican Information Service reports that nearly half of the country's approximately 32,000 HIV-positive residents do not know they are infected. Streamlining records is a key objective to study and treat the diseases.
The UB program is based on similar successes of an education and research training program in Zimbabwe, led by Gene D. Morse, PharmD, with the UB CBLS. "The overarching goal of this new collaboration is to bring Buffalo expertise in healthcare systems to an academic, business, government partnership that will promote healthcare, education, technology, and business development in Jamaica and Western New York," says Morse. The collaboration will train young scientists in laboratory sciences and HIV implementation research.
| | Read Full Article | Share this Article | | Back to Top | | | Medical News  | Cervical Cancer Vaccinations Are Globally Effective and Economical GLOBAL :: STDs
HealthCanal (06.13.2014) | | | Health Canal reported on a global study of the cost-effectiveness and health effects of the human papillomavirus (HPV) vaccine. Researchers from the London School of Hygiene & Tropical Medicine and the World Health Organization (WHO) assessed the projected cost-effectiveness and health effects of HPV vaccine in terms of cervical cancer and lifetime mortality rates for all 12-year-old girls in 179 countries. They projected the vaccine to be very cost-effective in 87 percent of countries, leading researchers to state that the HPV vaccine would be a good value for its cost in almost every country in the world.
The researchers noted large vaccination disparities between countries due to the fact that many countries that would gain the most have not yet introduced national HPV vaccination programs. Of the 33 countries in which HPV vaccination probably would have the greatest effect by preventing more than 2,500 cancers per 100,000 girls vaccinated, 26 had not begun national vaccination by October 2013. The majority of these countries are in sub-Saharan Africa. According to Dr. Mark Jit, senior lecturer in vaccine epidemiology at the London School of Hygiene & Tropical Medicine and the lead author of the study, their calculations indicate that the vaccine could prevent thousands of women from dying of cervical cancer every year due to support for the HPV vaccine in low-income countries. However, the number could be doubled if the world's poorest countries offered the vaccine.
The researchers contend that the HPV vaccine's cost-effectiveness could improve to even greater than the study reported, if the calculations included benefits such as herd protection, protection from non-cervical cancers, and cost savings from reduced cervical screening and treatment.
Study limitations include unsatisfactory data quality for most countries in African, Eastern Mediterranean, and Central Asian regions.
WHO funded the research, which was conducted in partnership with Université Laval, Canada, and US Johns Hopkins Bloomberg School of Public Health.
The full report, "Cost-Effectiveness of Female Human Papillomavirus Vaccination in 179 Countries: A PRIME Modelling Study," was published online in the journal The Lancet Global Health (2014; doi: 10.1016/S2214-109X(14)70237-2). | | Read Full Article | Share this Article | | Back to Top | | | Local and Community News  | Hepatitis C Testing Continues as NKY Rate Soars OHIO :: Viral Hepatitis
Cincinnati.com (06.18.2014) :: By Terry DeMio | | Cincinnati.com reported that while Kentucky has seen an overall decrease in hepatitis C virus (HCV) cases, northern counties have triple the state rate and 10 times the nation's rate. Northern Kentucky reported 9.5 cases per 100,000 individuals in 2011, while the state saw three cases per 100,000, and the overall US rate was one per 100,000. Officials attribute the climbing rate to a regional heroin epidemic, because people use and share needles to inject the drug. "We've seen an 80-percent increase in 2013 (over) 2010," said Jessica Schultz, an epidemiologist with the Northern Kentucky Health Department who investigates HCV. The state legislature and law enforcement stemmed the supply of painkillers, which pushed hundreds of people to use heroin. The health department offers free HCV testing in all four Northern Kentucky counties: Boone, Campbell, Kenton, and Grant. The counties average 90 people getting tested each month, but only report results for acute HCV. Acute HCV is experienced within the first six months of infection, but often can lead to chronic HCV, which can cause cirrhosis, cancer, liver failure, and death. According to the health department, 264 people have tested positive for chronic HCV since 2012, and 81 percent of those people reported a history of injecting drug use. Hepatitis C often presents no symptoms until the disease has progressed. CDC recommends testing for anyone at high risk for HCV. Treatment now is available for sufferers of HCV. For additional information, visit www.nkyhealth.org. | | Read Full Article | Share this Article | | Back to Top | | | | News Briefs | | | | | The CDC National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention provides the above information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, viral hepatitis, other sexually transmitted diseases, and tuberculosis does not constitute CDC endorsement. The above summaries were prepared without conducting any additional research or investigation into the facts and statements made in the articles being summarized, and therefore readers are expressly cautioned against relying on the validity or invalidity of any statements made in these summaries. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/Hepatitis/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted above for full texts of the articles. The Prevention News Update electronic mailing list is maintained by the National Prevention Information Network (NPIN), part of the Centers for Disease Control and Prevention's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Regular postings include the Prevention News Update, select articles from the Morbidity and Mortality Weekly Report series, and announcements about new NPIN products and services. | |
No comments:
Post a Comment